drugset / Trial / NCT06107036
A Study in Healthy People to Test Whether Different Doses of BI 1015550 Have Potential to Induce Heart Rhythm Abnormalities
RandomizedCrossoverDouble-blindTreatment
Summary
The main objective of this trial is to evaluate the effects of a single therapeutic and a single supra-therapeutic dose of BI 1015550 following oral administration on cardiac safety parameters in healthy male and female volunteers.
Timeline
- Start
- 2024-03-06
- Primary completion
- 2024-07-25
- Completion
- 2024-07-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Moxifloxacin | Small molecule | — | Oral |
| Subject | Nerandomilast | Small molecule | — | Oral |
Indications
No indication recorded.